We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » BIO Endorses WHO’s Proposed Name ‘Qualifiers’ for Biosimilars
BIO Endorses WHO’s Proposed Name ‘Qualifiers’ for Biosimilars
The U.S. biotechnology industry has endorsed a recent World Health Organization proposal to give biosimilar products a unique name qualifier that distinguishes them from the reference products’ nonproprietary name, a proposal that may run counter to naming protocols in the generic drug industry.